Zydus & CMS enter pact for Desidustat in Greater China

Pharma firm Zydus has entered into a licensing pact with China Medical System Holdings Ltd (CMS) for the development and commercialisation of Desidustat, an innovative candidate, in Greater China.<...

Sun Pharma, US-based Rockwell Medical enter into licensing pact for Triferic

Sun Pharmaceutical Industries has entered into a licensing agreement with US-based Rockwell Medical to commercialise Triferic, which is an iron replacement and haemoglobin maintenance drug in India...

Strides gets USFDA nod for anti-allergic drug

Strides Pharma Science received approval from the US health regulator for Loratadine Softgel Capsules, which is typically used to treat seasonal allergy (seasonal allergic rhinitis) and other upper...

Alembic gets USFDA nod for capsules used to treat spasticity

Drug firm Alembic Pharmaceuticals has received final nod from the US health regulator for Tizanidine hydrochloride capsules, which is used to treat spasticity.

Lupin gets USFDA nod to market skin ointment

Lupin has received the USFDA's approval to market its Betmethasone Dipropionate ointment (augmented) in United States of America (USA).

Panacea Biotec bags orders worth US$ 24 million from UN agencies

Panacea Biotec has bagged orders worth around Rs 170 crore (US$ 24.32 million) from UN agencies, including UNICEF, for supply of Pentavalent vaccine.

Pharma sector expected to grow at 10-12 per cent during FY19-22, outlook stable: ICRA

Indian pharmaceutical industry is expected to grow around 10-12 per cent between FY19 and FY22: ICRA

CSIR Developed Anti-Diabetes Medicine

Council of Scientific and Industrial Research (CSIR), through its constituent laboratories developed scientifically validated herbal product NBRMAP-DB as anti-diabetic formulation and the knowhow f...